Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...

Holding signs and banners reading Stop the AI Race and Don’t Build Skynet, the protesters marched through the city and gave ...

There is something almost disarmingly sincere about youth orchestras; an openness of gesture, a lack of defensive irony, that ...

Evotec SE (NASDAQ:EVO) Q4 2025 Earnings Call Transcript April 8, 2026 Evotec SE reports earnings inline with expectations. Reported EPS is $0.2098 EPS, expectations were $0.2098. Operator: Ladies and ...

Rick and Morty became of the most popular animated series ever thanks to its willingness to poke fun at sci-fi with wacky ...

The Kill Chain models how an attack succeeds. The Attack Helix models how the offensive baseline improves. Tipping Points One person. Two AI subscriptions. Ten government agencies. 150 gigabytes of ...

A Google Students mock interview video offers insights into how candidates are assessed in technical interviews at Google. The session demonstrates a coding problem involving finding the largest ...

The best systems programming books focus on both theory and hands-on practice, making tough topics easier to grasp. They ...

Meta AI launches Archimedes, its first superintelligence model from $10B research team. Performance specs, access details & industry impact analysis.

From Watson's $15B Jeopardy-to-medicine failure to 800+ FDA-cleared AI tools: the complete history of AI in healthcare.

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Drug Discovery Software Market OverviewThe global drug discovery software market is emerging as a high-impact segment within the life sciences technology ecosystem, driven by the urgent need for ...